GLP-1 agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Monjaro, Zepbound) have become powerful tools for weight loss and metabolic health
In the U.S., MOUNJARO (tirzepatide) is indicated as an adjunct to diet and exercise for glycemic control in adults and pediatric patients aged 10 years and older with insufficiently controlled type 2 diabetes mellitus as monotherapy when metformin is not appropriate, or in addition to other antidiabetic agents.[4] MOUNJARO does not carry a U.S
Get the prescription written for branded Zepbound
Inform your surgical and anaesthetic team of any supplements you are taking
An Introduction to Tirzepatide and Ozempic When it comes to managing diabetes, there are various medications available that can help individuals regulate their blood sugar levels effectively
Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury